Meeting Coverage:

American Academy of Ophthalmology

AAO: 2019

MIGS in Patients With Corneal Disease

Show Description +

With 48% to 60% of patients who are on glaucoma medications suffering from dry eye, John P. Berdahl, MD, examines ways to alleviate the medication burden for glaucoma through microinvasive glaucoma surgery (MIGS) in patients with corneal disease.

Posted: 10/02/2019

Up Next

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

PANORAMA Study Data

Rishi P. Singh, MD

Gene Therapy for Wet AMD

Szilard Kiss, MD

ABC to Block VEGF-A Isoforms

Charles C. Wykoff, MD, PhD

Surgery for Viral Retinitis

J. Fernando Arevalo, MD, PhD, FACS

Iridocorneal Endothelial Syndrome

Lauren S. Blieden, MD

Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Efficacy of Presbyond for the Correction of Presbyopia

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Autonomous AI in Ophthalmology

Michael D. Abramoff, MD, PhD

CXL for Infectious Keratitis

Farhad Hafezi, MD, PhD, FARVO

MIGS and Medications

Alex Huang, MD

Controlling Wound Healing Following PRK

Farhad Hafezi, MD, PhD, FARVO

MIGS in Patients With Corneal Disease

With 48% to 60% of patients who are on glaucoma medications suffering from dry eye, John P. Berdahl, MD, examines ways to alleviate the medication burden for glaucoma through microinvasive glaucoma surgery (MIGS) in patients with corneal disease.

Posted: 10/02/2019


Please log in to leave a comment.

More From AAO: 2019 Coverage

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS